SCHEMBL4861453

SCHEMBL4861453

CSc1ccc(C(N)c2ccc(C(C)C)cc2)cc1

nearest known ligand 0.53

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC6A4 P31645 7/20 0.53
MAOA P21397 1/20 0.48
SLC6A2 P23975 1/20 0.48
SLC6A3 Q01959 1/20 0.48
ALOX5 P09917 1/20 0.41
HTT P42858 2/20 0.38
AKR1C3 P42330 3/20 0.37
AKR1C2 P52895 3/20 0.37
ADRB2 P07550 1/20 0.37
ACACB O00763 1/20 0.37
ALDH1A1 P00352 1/20 0.36
GAA P10253 1/20 0.36
ALOX12 P18054 1/20 0.36
HIF1A Q16665 1/20 0.36
NOS3 P29474 1/20 0.36
NOS1 P29475 1/20 0.36
IDO1 P14902 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4556108 0.89 SLC6A4 (0.52) SLC6A4MAOASLC6A2SLC6A3ALOX5
SCHEMBL24894227 0.82 SLC6A4 (0.47) SLC6A4MAOASLC6A2SLC6A3ALOX5
SCHEMBL7330731 0.79 SLC6A4 (0.59) SLC6A4MAOASLC6A2SLC6A3AKR1C3
Hydrochloric Acid SCHEMBL31502318 0.77 SLC6A4 (0.57) SLC6A4MAOASLC6A2SLC6A3AKR1C3
Hydrochloric Acid SCHEMBL7628639 0.77 SLC6A4 (0.57) SLC6A4MAOASLC6A2SLC6A3AKR1C3
Hydrochloric Acid SCHEMBL31502313 0.77 SLC6A4 (0.57) SLC6A4MAOASLC6A2SLC6A3AKR1C3
SCHEMBL22167223 0.77 ALOX5 (0.43) SLC6A4MAOASLC6A2SLC6A3ALOX5
SCHEMBL20215796 0.77 SLC6A4 (0.47) SLC6A4MAOASLC6A2SLC6A3ALOX5
SCHEMBL24664459 0.75 ADRA2A (0.48) HTTADRB2ALDH1A1HIF1A
SCHEMBL23917846 0.74 PLK1 (0.48) SLC6A4ALOX5HTTAKR1C3AKR1C2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7429666-B2 antiinflammatory agents; N-[4-(Dimethylamino)benzyl]-N-(4-isopropylphenyl)-2-methoxy-5,6,7,8-tetrahydroquinoline-8-carboxamide MERCK FROSST CANADA LTD. (CA) 2008-09-30 US disclosed
US-20050277644-A1 antiinflammatory agents; N-[4-(Dimethylamino)benzyl]-N-(4-isopropylphenyl)-2-methoxy-5,6,7,8-tetrahydroquinoline-8-carboxamide MERCK FROSST CANADA LTD. (CA) 2005-12-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050277644-A1 antiinflammatory agents; N-[4-(Dimethylamino)benzyl]-N-(4-isopropylphenyl)-2-methoxy-5,6,7,8-tetrahydroquinoline-8-carboxamide C5AR2, C5AR1, C3AR1 SLC6A4 2860/4885MAOA 771/4885SLC6A2 2581/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.